Vimarsana
Biggest News Aggregation in the World

Wei Zuo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wei Zuo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wei Zuo Today - Breaking & Trending Today

Transplanting patients' own lung cells could 'cure' COPD - Vimarsana News

Transplanting patients' own lung cells could 'cure' COPD

Researchers have shown that it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease (COPD) using the patients' own lung cells.

COPD patients see promise of new therapies to ease discomfort, aid breathing - Vimarsana News

COPD patients see promise of new therapies to ease discomfort, aid breathing

Recent advances in chronic obstructive pulmonary disease offer patients more hope in easing discomfort from a condition that can cause severe airflow blockage and breathing-related problems.

Source: upi.com
ERS Roundup: Cell Transplant Boosts Lung Function in COPD Patients - Vimarsana News

ERS Roundup: Cell Transplant Boosts Lung Function in COPD Patients

Plus: idrevloride for primary ciliary dyskinesia and ultrasound for pulmonary embolism

A Cure for COPD? Transplanting Patients' Own Lung Cells Shows Great Promise - Vimarsana News

A Cure for COPD? Transplanting Patients' Own Lung Cells Shows Great Promise

Researchers have demonstrated the potential to heal injured lung tissue in chronic obstructive pulmonary disease (COPD) patients using their own lung cells for the first time. A study recently presented at the European Respiratory Society International Congress in Milan, Italy reported that 17 pa

Transplanting patients' own lung cells offers - Vimarsana News

Transplanting patients' own lung cells offers

For the first time, researchers have shown it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease (COPD) using the patients’ own lung cells. The European Respiratory Society International Congress in Milan, Italy, heard that 17 patients who took part in a phase I clinical trial were able to breath better, walk further and had better quality of life after receiving the experimental treatment.